WASHINGTON — A drug pricing advocacy group on Thursday announced a roughly $1 million ad campaign to boost a Trump administration proposal to align American drug prices with those in other wealthy nations, providing an outside boost to a policy concept that the drug industry has vocally opposed.
The same advocacy group, Patients for Affordable Drugs, spent $10 million via its political arm to endorse midterm election candidates it said were working to lower drug costs — and to oppose candidates it said were in bed with industry.
It is amusing how the real Americans “don’t want foreign countries setting our drug prices”, although it is not clear why it would be such a despicable thing. And, on the other hand, they are perfectly fine with Russia manipulating US elections and politics
The US medical drug supply chain from drug maker to patient contributes substantially to the “cost of drugs” in the USA. Cut out a huge chunk of the interim handlers and their “incentive discounts”, put curbs on the extravagant advertising and lobbying allowances, and the cost would foreseeably come down dramatically.
Comments are closed.